Gastrointestinal Stromal Tumors: all 345 studies
Page 2 of 4. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)CompletedNCT00867113Phase 2Results posted
- Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal TumorCompletedNCT00793871Phase 4Results posted
- A Study of Nilotinib Versus Imatinib in GIST PatientsCompletedNCT00785785Phase 3Results posted
- Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST)TerminatedNCT00782834Phase 2Results posted
- Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric CarcinomaCompletedNCT00780494Phase 2Results posted
- Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With NilotinibCompletedNCT00756509Phase 4Results posted
- Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 MgTerminatedNCT00751036Phase 3Results posted
- Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).CompletedNCT00716820Results posted
- Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]CompletedNCT00700258Results posted
- A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 AntigenCompletedNCT00623831Phase 1Results posted
- Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) PatientsTerminatedNCT00585221Phase 2Results posted
- Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of CoquimboCompletedNCT00564265Results posted
- Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and SunitinibCompletedNCT00471328Phase 3Results posted
- Trial of Dasatinib in Advanced SarcomasCompletedNCT00464620Phase 2Results posted
- A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)CompletedNCT00457743Phase 1/2Results posted
- Post Marketing Surveillance Study To Observe Safety And Efficacy Of SuteneCompletedNCT00444795Results posted
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.CompletedNCT00428220Not applicableResults posted
- The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).CompletedNCT00385203Phase 2Results posted
- Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal TumorsTerminatedNCT00372567Phase 3Results posted
- Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal TumorTerminatedNCT00324987Phase 3Results posted
- Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit MutationCompletedNCT00278876Phase 2Results posted
- Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib MalateActive, not recruitingNCT00265798Phase 2Results posted
- A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit GeneCompletedNCT00237185Phase 2Results posted
- Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal TumorCompletedNCT00137449Phase 2Results posted
- Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaCompletedNCT00112463Phase 2Results posted
- A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)CompletedNCT00075218Phase 3Results posted
- Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal TumorCompletedNCT00028002Phase 2Results posted
- Development and External Validation of a Prognostic Model for DFS After Curative Resection of Duodenal GISTActive, not recruitingNCT07837271
- To Explore the Optimal Therapeutic Window for Imatinib in the Adjuvant Treatment of Intermediate and High-risk Gastrointestinal Stromal TumorsCompletedNCT07614841
- Development of a Multimodal AI System for GIST ManagementCompletedNCT07454967
- ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin ReactionCompletedNCT06856590Not applicable
- Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different GenotypesCompletedNCT06628739
- Ripretinib (QINLOCK®) According to Current SmPCCompletedNCT06619275
- An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United StatesCompletedNCT06321055
- SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GISTActive, not recruitingNCT06208748Phase 2
- Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.Active, not recruitingNCT06087263Phase 2
- A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced MalignanciesActive, not recruitingNCT05957367Phase 1/2
- A Prospective Study on Predicting Recurrence Risk of Postoperative High-risk GISTs in NED State Based on MRD Detection Via Liquid BiopsySuspendedNCT05867901
- A Bioequivalence Study of Sunitinib Malate Capsules.CompletedNCT05800106Phase 1
- A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With ImatinibActive, not recruitingNCT05734105Phase 3
- Ripretinib in Chinese Patients With Advanced GIST: a Real World StudyStatus unknownNCT05697107
- Study on Integrated Nursing Strategy for Patients With Gastrointestinal Stromal Tumors After Targeted TherapyStatus unknownNCT05665868Not applicable
- A Real-world Comparison of FNB and FNA in IHC-required Lesions.CompletedNCT05565066
- First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorsActive, not recruitingNCT05489237Phase 1
- Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
- Clinical Evaluation of Genetron D842V PCR Kit in GIST PatientsCompletedNCT05400018
- Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real WorldCompletedNCT05381753
- Ripretinib Combined With Surgery in Advanced GIST That Have Failed Imatinib Therapy: A Multicenter,Observational StudyStatus unknownNCT05354388
- A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)Active, not recruitingNCT05245968Phase 1
- Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of StomachStatus unknownNCT05197933Not applicable
- The GALLOP-11 StudyCompletedNCT05178030
- A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard TreatmentsActive, not recruitingNCT05152472Phase 2
- Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib TherapyStatus unknownNCT05132738Not applicable
- Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)WithdrawnNCT05080621Phase 1/2
- 68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal TumorStatus unknownNCT05001204Early Phase 1
- French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST PatientsActive, not recruitingNCT04927260
- A Drug-drug Interaction Study of Avapritinib and MidazolamCompletedNCT04908176Phase 1
- GIST and Memory and Attention Adaptation TrainingTerminatedNCT04879979Not applicable
- Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor PatientsActive, not recruitingNCT04821895
- Gastrointestinal Anastomosis Using MonoPlus® SutureWithdrawnNCT04811833
- Study On Safety Of Endoscopic Resection For 2-5cm Gastric Gastrointestinal Stromal TumorStatus unknownNCT04751591Not applicable
- DNX-2440 for Resectable Colorectal Liver MetastasisSuspendedNCT04714983Phase 1
- Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)CompletedNCT04599660
- Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)Active, not recruitingNCT04595747Phase 2
- Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular CharacteristicsActive, not recruitingNCT04584008Not applicable
- Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid BiopsiesCompletedNCT04566614
- A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GISTCompletedNCT04530981Phase 1
- Outcome After Surgical Resection of Gastrointestinal Stromal Tumors (GIST) in the Second Part of DuodenumCompletedNCT04487002Not applicable
- Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of ImatinibTerminatedNCT04409223Phase 3
- Incidental Finding of Gastrointestinal Stromal Tumors (GISTs) During Laparoscopic Sleeve Gastrectomy, How to Deal? How Much Safety MarginStatus unknownNCT04344847Not applicable
- Salvage Surgery for Patients With Metastatic GIST With RegoCompletedNCT04343456
- A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard TherapyCompletedNCT04258956Phase 2
- Clinical Outcome of Female Non-gastric Gastrointestinal Stromal TumorCompletedNCT04256226
- A Study of CS3007 in Subjects With Gastrointestinal Stromal TumorCompletedNCT04254939Phase 1/2
- Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GISTApproved for marketingNCT04148092
- A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant NodulesStatus unknownNCT04143048
- Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)Active, not recruitingNCT04138381Phase 1/2
- Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter TrialStatus unknownNCT04106024Phase 2
- Entacapone Combination With Imatinib for Treatment of GISTCompletedNCT04006769Early Phase 1
- Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesTerminatedNCT04000529Phase 1
- Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.CompletedNCT03944304Phase 2
- Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib TreatmentStatus unknownNCT03862768Not applicable
- Laparoscopic Management of Gastrointestinal Stromal Tumor of StomachCompletedNCT03722056
- PDR001 Plus Imatinib for Metastatic or Unresectable GISTCompletedNCT03609424Phase 1/2
- Observational Registry Data on GIST PatientsCompletedNCT03602092
- Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal TumorsStatus unknownNCT03601234Not applicable
- Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)No longer availableNCT03493152
- Comparison of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal TumorStatus unknownNCT03471273Not applicable
- Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal TumorCompletedNCT03440515Phase 2
- L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal TumorsCompletedNCT03426722Phase 3
- Unifying Advanced Treatment With Advanced ImagingCompletedNCT03404076
- Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center StudyCompletedNCT03238820Not applicable
- POETIG Trial - POnatinib After rEsisTance to Imatinib in GISTStatus unknownNCT03171389Phase 2
- A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)CompletedNCT03158103Phase 1
- A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismStatus unknownNCT03139487Phase 2
- Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)WithdrawnNCT03109301Phase 2
- A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor TreatmentStatus unknownNCT03092128
- Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm)Status unknownNCT03082079Not applicable
- A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial CarcinomaStatus unknownNCT02982486Phase 2
- Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal TumorStatus unknownNCT02931981